– Hancom MDS acquires 63.4% of Carelink shares… Promoting digital healthcare business based on data analysis
Hancom Group (Chairman Sang-cheol Kim, hereinafter referred to as Hancom Group) will acquire a 63.4% stake in ‘CareLink’, a total healthcare service company, through Hancom MDS (CEO Chang-yeol Lee, Dong-wook Jeon/086960).
Hancom MDS promotes a data analysis-based digital healthcare business by linking its artificial intelligence (AI) technology and cloud business with CareLink’s healthcare technology and service capabilities.
To this end, we provide ‘customized health examination and health management services’ in which AI designs health examinations based on customer consent data, and we establish our own genetic testing laboratory to develop specialized services based on genetic data.
In particular, Hancom MDS plans to advance into the digital healthcare business through this acquisition and reduce its dependence on the embedded solution business by expanding the proportion of new businesses such as artificial intelligence, cloud, mobility, and metaverse and diversifying its business portfolio.
In addition, Hancom Group is also looking forward to creating synergies with the group’s healthcare businesses, such as group company Hancom Healthcare’s diagnostic kit and diagnostic solution business and Hancom People’s senior care service.
Established in 2016, CareLink (CEO Cheon Chang-gi) provides data-centered total healthcare services specialized in health screening and health management, including the health screening agency platform (app/web) ‘Care Health’ and genetic testing services.
Currently, we have secured the widest and most stable screening network in the industry by partnering with 410 hospitals nationwide, and based on this, we are providing health screening services suited to the characteristics and needs of each customer. In particular, it has launched a customized health care service that combines genetic testing and health checkups for the first time in Korea, and has differentiated technology and competitiveness, including patented AI-based health checkup item recommendation technology and possession of more than 100,000 pieces of medical data.
Meanwhile, according to the Ministry of SMEs and Startups, the global digital healthcare market size is expected to be approximately 409 trillion won by 2023, and the domestic market is also expected to grow at an average annual rate of more than 16% to 11.7 trillion won.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2021’ news